Neuroma Clinical Trial
Official title:
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
PROSPECTIVE COHORT EVALUATION OF NEUROCAP® In the Treatment of symptomatic Neuroma (PROTECT
Neuro)
This post-market surveillance study is conducted to provide post market surveillance
information regarding long-term performance and ease of use of the Polyganics nerve capping
device (NEUROCAP®) for reduction of the development of peripheral symptomatic end-neuroma.
1. Device description NEUROCAP®, a bioresorbable nerve capping device based upon the
NEUROLAC® nerve guide, is indicated to protect a peripheral nerve end and to separate
the nerve from surrounding environment to reduce the development of a symptomatic
neuroma. NEUROCAP® is composed of the same biocompatible, bioresorbable copolyester
composing the NEUROLAC® nerve guide, Poly(68/32[15/85 D/L] Lactide-Ԑ-Caprolactone)
(PLCL).
2. Objective This post-market surveillance study is conducted to provide post market
surveillance information regarding long-term performance and ease of use of the
Polyganics nerve capping device (NEUROCAP®) for reduction of the development of
peripheral symptomatic end-neuroma.
3. Study design This post-market surveillance study consists of a cohort study to provide
post market surveillance information regarding long-term performance and ease of use of
the NEUROCAP® for reduction of the development of peripheral symptomatic end-neuroma in
the upper and lower extremity. Sub analyses will be performed regarding demographics and
medical background.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02930551 -
Neuromas as the Cause of Pain
|
N/A | |
| Completed |
NCT00130962 -
ALGRX 4975 in the Treatment of Patients With Morton's Neuroma
|
Phase 2 | |
| Recruiting |
NCT05008185 -
Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation
|
||
| Completed |
NCT02205385 -
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
|
N/A | |
| Completed |
NCT02316262 -
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
|
N/A | |
| Completed |
NCT04931056 -
A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.
|
||
| Completed |
NCT01632709 -
Pathophysiology of Post Amputation Pain
|
Phase 4 | |
| Completed |
NCT02528266 -
Surgical Treatment of Symptomatic Neuroma "Stop Neuroma"
|
N/A | |
| Withdrawn |
NCT01374191 -
Botulinum Toxin Type A for Neuroma Pain
|
Phase 2 | |
| Enrolling by invitation |
NCT06164392 -
Evaluation of Neuroma Perfusion With Indocyanine Green Fluorescence Angiography
|
Phase 4 | |
| Completed |
NCT03484429 -
Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain
|
N/A | |
| Completed |
NCT03051113 -
Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations
|